Exact Mass: 447.2291
Exact Mass Matches: 447.2291
Found 500 metabolites which its exact mass value is equals to given mass value 447.2291
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Palbociclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ronacaleret
2-(2H-Benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol
(1S,3R,17S,19S)-3-Hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.01,17 03,15 04,13 07,12 019,23]hexacosa-4,6,10,12,14-pentaene-24,26-dione
Thr Lys Ala Glu
C26H29N3O4_8H,10H-7a,12a-(Iminomethano)indolizino[6,7-h]pyrano[3,2-a]carbazole-8,16-dione, 3,6b,7,11,12,13,13a,14-octahydro-6b-hydroxy-3,3,14,14-tetramethyl-, (6bR,7aS,12aS,13aS)
(1S,3R,17S,19S)-3-hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-4,6,10,12,14-pentaene-24,26-dione
Ala Ala Met Arg
Ala Ala Arg Met
Ala Cys Arg Val
Ala Cys Val Arg
Ala Glu Lys Thr
Ala Glu Thr Lys
Ala Lys Glu Thr
Ala Lys Thr Glu
Ala Met Ala Arg
Ala Met Arg Ala
Ala Arg Ala Met
Ala Arg Cys Val
Ala Arg Met Ala
Ala Arg Val Cys
Ala Thr Glu Lys
Ala Thr Lys Glu
Ala Val Cys Arg
Ala Val Arg Cys
Cys Ala Arg Val
Cys Ala Val Arg
Cys Gly Ile Arg
Cys Gly Leu Arg
Cys Gly Arg Ile
Cys Gly Arg Leu
Cys Ile Gly Arg
Cys Ile Arg Gly
Cys Leu Gly Arg
Cys Leu Arg Gly
Cys Arg Ala Val
Cys Arg Gly Ile
Cys Arg Gly Leu
Cys Arg Ile Gly
Cys Arg Leu Gly
Cys Arg Val Ala
Cys Val Ala Arg
Cys Val Leu Asn
Cys Val Asn Ile
Cys Val Asn Leu
Cys Val Gln Val
Cys Val Arg Ala
Cys Val Val Gln
Asp Lys Ser Val
Asp Lys Val Ser
Asp Ser Lys Val
Asp Ser Val Lys
Asp Val Lys Ser
Asp Val Ser Lys
Glu Ala Lys Thr
Glu Ala Thr Lys
Glu Lys Ala Thr
Glu Lys Thr Ala
Glu Thr Ala Lys
Glu Thr Lys Ala
Gly Cys Ile Arg
Gly Cys Leu Arg
Gly Cys Arg Ile
Gly Cys Arg Leu
Gly Ile Cys Arg
Gly Ile Met Gln
Gly Ile Gln Met
Gly Ile Arg Cys
Gly Leu Cys Arg
Gly Leu Met Gln
Gly Leu Gln Met
Gly Leu Arg Cys
Gly Met Ile Gln
Gly Met Leu Gln
Gly Met Gln Ile
Gly Met Gln Leu
Gly Gln Ile Met
Gly Gln Met Ile
Gly Gln Met Leu
Gly Arg Cys Ile
Gly Arg Cys Leu
Gly Arg Ile Cys
Gly Arg Leu Cys
Ile Ala Met Asn
Ile Ala Asn Met
Ile Cys Gly Arg
Ile Cys Asn Val
Ile Cys Arg Gly
Ile Cys Val Asn
Ile Gly Cys Arg
Ile Gly Met Gln
Ile Gly Gln Met
Ile Gly Arg Cys
Ile Met Ala Asn
Ile Met Gly Gln
Ile Met Asn Ala
Ile Met Gln Gly
Ile Asn Ala Met
Ile Asn Cys Val
Ile Asn Met Ala
Ile Asn Thr Thr
Ile Asn Val Cys
Ile Gln Gly Met
Ile Gln Met Gly
Ile Gln Ser Thr
Ile Gln Thr Ser
Ile Arg Cys Gly
Ile Arg Gly Cys
Ile Ser Gln Thr
Ile Ser Thr Gln
Ile Thr Asn Thr
Ile Thr Gln Ser
Ile Thr Ser Gln
Ile Thr Thr Asn
Ile Val Cys Asn
Ile Val Asn Cys
Lys Ala Glu Thr
Lys Ala Thr Glu
Lys Cys Pro Thr
Lys Cys Thr Pro
Lys Asp Ser Val
Lys Asp Val Ser
Lys Glu Ala Thr
Lys Glu Thr Ala
Lys Pro Cys Thr
Lys Pro Thr Cys
Lys Ser Asp Val
Lys Ser Val Asp
Lys Thr Ala Glu
Lys Thr Cys Pro
Lys Thr Glu Ala
Lys Thr Pro Cys
Lys Val Asp Ser
Lys Val Ser Asp
Leu Cys Gly Arg
Leu Cys Arg Gly
Leu Gly Cys Arg
Leu Gly Met Gln
Leu Gly Gln Met
Leu Gly Arg Cys
Leu Met Ala Asn
Leu Met Gly Gln
Leu Met Asn Ala
Leu Met Gln Gly
Leu Asn Ala Met
Leu Asn Cys Val
Leu Asn Met Ala
Leu Asn Thr Thr
Leu Asn Val Cys
Leu Gln Gly Met
Leu Gln Met Gly
Leu Gln Ser Thr
Leu Gln Thr Ser
Leu Arg Cys Gly
Leu Arg Gly Cys
Leu Ser Gln Thr
Leu Ser Thr Gln
Leu Thr Asn Thr
Leu Thr Gln Ser
Leu Thr Ser Gln
Leu Thr Thr Asn
Leu Val Cys Asn
Leu Val Asn Cys
Met Ala Ala Arg
Met Ala Ile Asn
Met Ala Leu Asn
Met Ala Asn Ile
Met Ala Asn Leu
Met Ala Gln Val
Met Ala Arg Ala
Met Ala Val Gln
Met Gly Ile Gln
Met Gly Leu Gln
Met Gly Gln Ile
Met Ile Ala Asn
Met Ile Gly Gln
Met Ile Asn Ala
Met Ile Gln Gly
Met Leu Ala Asn
Met Leu Gly Gln
Met Leu Asn Ala
Met Leu Gln Gly
Met Asn Ala Ile
Met Asn Ala Leu
Met Asn Ile Ala
Met Asn Leu Ala
Met Gln Ala Val
Met Gln Gly Ile
Met Gln Gly Leu
Met Gln Ile Gly
Met Gln Leu Gly
Met Gln Val Ala
Met Arg Ala Ala
Met Val Ala Gln
Met Val Gln Ala
Asn Ala Ile Met
Asn Ala Leu Met
Asn Ala Met Ile
Asn Ala Met Leu
Asn Cys Ile Val
Asn Cys Leu Val
Asn Cys Val Ile
Asn Cys Val Leu
Asn Ile Ala Met
Asn Ile Cys Val
Asn Ile Met Ala
Asn Ile Thr Thr
Asn Ile Val Cys
Asn Leu Ala Met
Asn Leu Cys Val
Asn Leu Met Ala
Asn Leu Thr Thr
Asn Leu Val Cys
Asn Met Ala Ile
Asn Met Ala Leu
Asn Met Ile Ala
Asn Met Leu Ala
Asn Thr Ile Thr
Asn Thr Leu Thr
Asn Thr Thr Ile
Asn Thr Thr Leu
Asn Val Cys Ile
Asn Val Cys Leu
Asn Val Ile Cys
Asn Val Leu Cys
Pro Cys Lys Thr
Pro Cys Thr Lys
Pro Lys Cys Thr
Pro Lys Thr Cys
Pro Thr Cys Lys
Pro Thr Lys Cys
Gln Ala Met Val
Gln Ala Val Met
Gln Cys Val Val
Gln Gly Ile Met
Gln Gly Leu Met
Gln Gly Met Ile
Gln Gly Met Leu
Gln Ile Gly Met
Gln Ile Met Gly
Gln Ile Ser Thr
Gln Ile Thr Ser
Gln Leu Gly Met
Gln Leu Met Gly
Gln Leu Ser Thr
Gln Leu Thr Ser
Gln Met Ala Val
Gln Met Gly Ile
Gln Met Gly Leu
Gln Met Ile Gly
Gln Met Leu Gly
Gln Met Val Ala
Gln Ser Ile Thr
Gln Ser Leu Thr
Gln Ser Thr Ile
Gln Ser Thr Leu
Gln Thr Ile Ser
Gln Thr Leu Ser
Gln Thr Ser Ile
Gln Thr Ser Leu
Gln Thr Thr Val
Gln Thr Val Thr
Gln Val Ala Met
Gln Val Cys Val
Gln Val Met Ala
Gln Val Thr Thr
Gln Val Val Cys
Arg Ala Ala Met
Arg Ala Cys Val
Arg Ala Met Ala
Arg Ala Val Cys
Arg Cys Ala Val
Arg Cys Gly Ile
Arg Cys Gly Leu
Arg Cys Ile Gly
Arg Cys Leu Gly
Arg Cys Val Ala
Arg Gly Cys Ile
Arg Gly Cys Leu
Arg Gly Ile Cys
Arg Gly Leu Cys
Arg Ile Cys Gly
Arg Ile Gly Cys
Arg Leu Cys Gly
Arg Leu Gly Cys
Arg Met Ala Ala
Arg Val Ala Cys
Arg Val Cys Ala
Ser Asp Lys Val
Ser Asp Val Lys
Ser Ile Gln Thr
Ser Ile Thr Gln
Ser Lys Asp Val
Ser Lys Val Asp
Ser Leu Gln Thr
Ser Leu Thr Gln
Ser Gln Ile Thr
Ser Gln Leu Thr
Ser Gln Thr Ile
Ser Gln Thr Leu
Ser Thr Ile Gln
Ser Thr Leu Gln
Ser Thr Gln Ile
Ser Thr Gln Leu
Ser Val Asp Lys
Ser Val Lys Asp
Thr Ala Glu Lys
Thr Ala Lys Glu
Thr Cys Lys Pro
Thr Cys Pro Lys
Thr Glu Ala Lys
Thr Glu Lys Ala
Thr Ile Asn Thr
Thr Ile Gln Ser
Thr Ile Ser Gln
Thr Ile Thr Asn
Thr Lys Cys Pro
Thr Lys Glu Ala
Thr Lys Pro Cys
Thr Leu Asn Thr
Thr Leu Gln Ser
Thr Leu Ser Gln
Thr Leu Thr Asn
Thr Asn Ile Thr
Thr Asn Leu Thr
Thr Asn Thr Ile
Thr Asn Thr Leu
Thr Pro Cys Lys
Thr Pro Lys Cys
Thr Gln Ile Ser
Thr Gln Leu Ser
Thr Gln Ser Ile
Thr Gln Ser Leu
Thr Gln Thr Val
Thr Gln Val Thr
Thr Ser Ile Gln
Thr Ser Leu Gln
Thr Ser Gln Ile
Thr Ser Gln Leu
Thr Thr Ile Asn
Thr Thr Leu Asn
Thr Thr Asn Ile
Thr Thr Asn Leu
Thr Thr Gln Val
Thr Thr Val Gln
Thr Val Gln Thr
Thr Val Thr Gln
Val Ala Cys Arg
Val Ala Met Gln
Val Ala Gln Met
Val Ala Arg Cys
Val Cys Ala Arg
Val Cys Ile Asn
Val Cys Leu Asn
Val Cys Asn Ile
Val Cys Asn Leu
Val Cys Gln Val
Val Cys Arg Ala
Val Cys Val Gln
Val Asp Lys Ser
Val Asp Ser Lys
Val Ile Cys Asn
Val Ile Asn Cys
Val Lys Asp Ser
Val Lys Ser Asp
Val Leu Cys Asn
Val Leu Asn Cys
Val Met Ala Gln
Val Met Gln Ala
Val Asn Cys Ile
Val Asn Cys Leu
Val Asn Ile Cys
Val Asn Leu Cys
Val Gln Ala Met
Val Gln Cys Val
Val Gln Met Ala
Val Gln Thr Thr
Val Gln Val Cys
Val Arg Ala Cys
Val Arg Cys Ala
Val Ser Asp Lys
Val Ser Lys Asp
Val Thr Gln Thr
Val Thr Thr Gln
Val Val Cys Gln
Val Val Gln Cys
Ronacaleret
C78281 - Agent Affecting Musculoskeletal System
(8R)-8-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]nonanoic acid
9-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]nonanoic acid
palbociclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS